ie manufacturing / regulatory communications / pharmaceutical development / pharmaceutical sales / biotechnology / pharmaceutical industry / pharmaceutical company benefits / biotechnology industry / pharmaceutical sector / mainstream pharmaceutical industry works / biotechnological products / pharmaceutical / drug products / clinical study protocols / biotechnology sector / /
Organization
European Federation of Pharmaceutical Industries / World Health Organization / ICH Secretariat / European Free Trade Association / Japanese Pharmaceutical Manufacturers Association / FDA / Minister’s Secretariat / European Union / Center for Drug Evaluation and Research / ICH Steering Committee / Steering Committee / International Federation of Pharmaceutical Manufacturers Associations / /
Person
Janet Woodcock / Glaxo Wellcome / John Niblack / Richard Sykes / Safety / Caroline Nutley / /
Position
Efficacy Director / Chairman / Peter Corr President / Executive / Osamu Doi Councillor / Executive Vice-President / General / Vice-President / Pfizer / Director of International Regulatory Affairs / /
VALUE BENEFITS The Value and Benefits of ICH to Industry International Conference on Harmonisation of Technical Requirements for Registration of